Evolving trends in risk profiles and causes of death after heart transplantation: A ten-year multi-institutional study

被引:85
|
作者
Kirklin, JK
Naftel, DC
Bourge, RC
McGiffin, DC
Hill, JA
Rodeheffer, RJ
Jaski, BE
Hauptman, PJ
Weston, M
White-Williams, C
机构
[1] Univ Alabama, Birmingham, AL 35293 USA
[2] Univ Florida, Shands Hosp, Gainesville, FL USA
[3] Mayo Clin, Rochester, MN USA
[4] Sharp Mem Hosp & Rehabil Ctr, La Jolla, CA USA
[5] St Louis Univ Hosp, St Louis, MO USA
[6] Tampa Gen Hosp, Tampa, FL 33606 USA
来源
关键词
D O I
10.1067/mtc.2003.168
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: As therapeutic options evolve for advanced heart failure, the appropriate role for cardiac transplantation will require survival analyses that reflect changing trends in causes of death and patient and institutional risk profiles. Results from multi-institutional studies could be used to monitor progress in individual centers. Methods: Between 1990 and 1999, 7290 patients undergoing cardiac transplantation in 42 institutions entered a formal outcomes study. Changing survival, causes of death, and patient risk profiles were analyzed. Multivariable risk-factor equations were applied to a single institution (300 primary heart transplants) to examine differences in risk-adjusted expected versus observed actuarial outcomes over time. Results: Overall survival in the 42 institutions improved during the decade (P = .02). One- and 3-year cardiac transplant research database survival was as follows: era 1 (1990-1992), 84% and 76%, respectively; era 2 (1993-1995), 85% and 79%, respectively; and era 3 (1996-1999), 85% and 79%, respectively. Causes of death changed over time. Pretransplantation risk profiles increased over time (P = .0001), with increases in reoperations, devices, diabetes, severely ill recipients, pulmonary vascular resistance, sensitization, ischemic times, donor age, and donor inotropic support. Three-year actuarial survival in a single institution was 3% less than risk-adjusted predicted survival in era 1, 1% higher than predicted in era 2, and 7% higher than predicted in era 3. Conclusions: Survival after cardiac transplantation is gradually improving, despite increasing risk profiles. Further improvement requires periodic re-evaluation of risk profiles and causes of death to target areas of surveillance, therapy, and research. By using these methods, progress at individual institutions can be assessed in a time-related, risk-adjusted manner that also reflects changing institutional experience, expertise, or both.
引用
收藏
页码:881 / 890
页数:10
相关论文
共 50 条
  • [41] A multi-institutional international study of risk factors for hematoma after thyroidectomy DISCUSSION
    Heller, Keith S.
    Campbell, Michael
    Snyder, Samuel K.
    Matzke, Gregory M.
    Linos, Dimitrios A.
    Evans, Douglas B.
    SURGERY, 2013, 154 (06) : 1289 - 1291
  • [42] Ten-year follow-up after paediatric heart transplantation in the Czech Republic:: Brno experience.
    Osmerova, M
    Cerny, J
    Némec, P
    Sirotkova, A
    PEDIATRIC TRANSPLANTATION, 2005, 9 : 120 - 120
  • [43] Has late rejection decreased in pediatric heart transplantation in the current era? A multi-institutional study
    Ameduri, Rebecca K.
    Zheng, Jie
    Schechtman, Kenneth B.
    Hoffman, Timothy M.
    Gajarski, Robert J.
    Chinnock, Richard
    Naftel, David C.
    Kirklin, James K.
    Dipchand, Anne I.
    Canter, Charles E.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (09): : 980 - 986
  • [44] Epidemiology of Pediatric Heart Failure in the USA-a 15-Year Multi-Institutional Study
    Morales-Demori, Raysa
    Montanes, Elena
    Erkonen, Gwen
    Chance, Michael
    Anders, Marc
    Denfield, Susan
    PEDIATRIC CARDIOLOGY, 2021, 42 (06) : 1297 - 1307
  • [45] Ten-Year Results of a Randomized Trial Comparing Tacrolimus Versus Cyclosporine A in Combination With Mycophenolate Mofetil After Heart Transplantation
    Guethoff, Sonja
    Meiser, Bruno M.
    Groetzner, Jan
    Eifert, Sandra
    Grinninger, Carola
    Ueberfuhr, Peter
    Reichart, Bruno
    Hagl, Christian
    Kaczmarek, Ingo
    TRANSPLANTATION, 2013, 95 (04) : 629 - 634
  • [46] Etiology of stroke after mechanical heart valve replacement - Results from a ten-year prospective study
    Hering, Cornelia Piper Detlef
    Langer, Christoph
    Horstkotte, Dieter
    JOURNAL OF HEART VALVE DISEASE, 2008, 17 (04): : 413 - 417
  • [47] Has Late Rejection Decreased in Pediatric Heart Transplantation in the Current Era? A Multi-institutional Study.
    Ameduri, Rebecca
    Zheng, Jie
    Schechtman, Kenneth
    Hoffman, Timothy
    Gajarski, Robert J.
    Chinnock, Richard E.
    Naftel, David C.
    Kirklin, James K.
    Dipchand, Anne I.
    Canter, Charles E.
    CIRCULATION, 2010, 122 (21)
  • [48] Outcomes of infants with pulmonary atresia with intact ventricular septum listed for heart transplantation: A multi-institutional study
    Joong, Anna
    Zuckerman, Warren A.
    Koehl, Devin
    Cantor, Ryan
    Alejos, Juan C.
    Ameduri, Rebecca K.
    Boyle, Gerard J.
    Rothkopf, Amy C.
    Kirklin, James K.
    Gajarski, Robert J.
    PEDIATRIC TRANSPLANTATION, 2022, 26 (07)
  • [49] Heart Transplantation Survival in Infants with Congenital Heart Disease with and without Prior Surgery (ws/wos): A Multi-Institutional Study
    Boyle, G. J.
    Guleserian, K. J.
    Zheng, J.
    Schectman, K.
    Everitt, M. D.
    Nasman, C. M.
    Canter, C. E.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (02): : S233 - S233
  • [50] Time Course and Predictors of Renal Function Decline After Pediatric Heart Transplantation: A PHTS Multi-Institutional Analysis
    Varma, Manu R.
    Richmond, Marc E.
    Koehl, Devin A.
    Aljohani, Othman A.
    Exil, Vernat J.
    Morrison, Adam K.
    Sheybani, Aryaz
    White, Shelby
    Cantor, Ryan S.
    Kirklin, James K.
    Eghtesady, Pirooz
    CIRCULATION, 2022, 146